Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology

Volumn 61, Issue 5, 2008, Pages 829-835

  Okuda, Kentaro ^a   Hirose, Takashi ^a   Ishida, Hiroo ^a   Kusumoto, Sojiro ^a   Sugiyama, Tomohide ^a   Ando, Kohichi ^a   Shirai, Takao ^a   Ohnishi, Tsukasa ^a   Horichi, Naoya ^a   Ohmori, Tohru ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Nedaplatin; Non small cell lung cancer; Phase I study; Weekly paclitaxel

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; DEXAMETHASONE; DIPHENHYDRAMINE; NEDAPLATIN; ONDANSETRON; OXYGEN; PACLITAXEL; RANITIDINE; STEROID;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTIPATION; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HERPES ZOSTER; HUMAN; HYPERSENSITIVITY REACTION; INFECTION; LEUKOPENIA; LIVER DYSFUNCTION; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MALE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA AND VOMITING; NEUROPATHY; PERFORMANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEVER; HUMANS; LIVER DISEASES; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 39749161001     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-007-0540-6     Document Type: Article

References (29)

1. Akerley W, Glantz M, Choy H, Rege V, Sambandam S, Joseph P, Yee L, Rodrigues B, Wingate P, Leone L (1998) Phase I trial of weekly paclitaxel in advanced lung cancer. J Clin Oncol 16:153-158
2. Belani CP, Barstis J, Perry MC, La Rocca RV, Nattam SR, Rinaldi D, Clark R, Mills GM (2003) Multicenter randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation. J Clin Oncol 21:2933-2939
3. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2:1843-1849
4. Bookman MA, Kloth DD, Kover PE, Smolinski S, Ozols RF (1997) Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions. Ann Oncol 8:611-614
5. Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, Yamaguchi Y (1992) A randomized comparative study of 254-S plus Vindesin (VDS) versus Cisplatin plus VDS in patients with advanced non-small cell lung cancer. Jpn J Cancer Chemothr 19:1019-1026 (in Japanese)
6. Georgiadis MS, Russell EK, Gazdar AF, Johnson BE (1997) Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations. Clin Cancer Res 3:449-454
7. Kelly K, Crowley J, Burn PA Jr, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara DR (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patient with advanced non-small-cell lung cancer: a southwest oncology group trial. J Clin Oncol 19:3210-3218
8. Klastersky J, Sculier JP, Lacroix H, Dabouis G, Bureau G, Libert P, Richez M, Ravez P, Vandermoten G, Thiriaux J (1990) A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 8:1556-1562
9. Koizumi T, Kubo K, Shinozaki S, Koyama S, Amari T, Hayano T, Fujimoto K, Kobayashi T, Sekiguchi M, Sakai R (1993) Pharmacokinetic evaluation of (glycolao-O,O′) diammine platinum (II) in lung lymph in sheep. Jpn J Cancer Res 84:468-473
10. Koumakis G, Demiri M, Barbounis V, Vassilomanolakis M, Gontikakis E, Pamouksoglou P, Dahabre J, Efremidis AP (2002) Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of phase II trial. Lung Cancer 35:315-317
11. Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J (2001) Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California cancer consortium phase II trial. J Clin Oncol 19:442-447
12. Lau D, Ryu J, Gandara D, Morgan R, Doroshow J, Wilder R, Leigh B (1999) Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small cell lung cancer. Semin Radiat Oncol 9:117-120
13. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB (1993) Cytotoxic studies of paclitaxel (Taxol) in human tumor cell lines. Br J Cancer 68:1104-1109
14. Oshita F, Yamada K, Kato Y, Ikehara M, Noda K, Tanaka G, Nomura I, Suzuki R, Saito H (2003) Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small cell lung cancer. Cancer Chemother Pharmacol 52:73-78
15. Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J, Lopez P, Anderson H, Gustafson N, Jeynes A, Gallant G, Washington T, Thatcher N (2000) Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 92:1074-1080
16. Reckzeh B, Merte H, Pfluger KH, Pfab R, Wolf M, Havemann K (1996) Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer. J Clin Oncol 14:1071-1076
17. Reshkin SJ, Bellizzi A, Cardone RA, Tommasino M, Casavola V, Paradiso A (2003) Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na(+)/H(+) exchanger (NHE) isoform 1 in human breast cancer cells. Clin Cancer Res 9:2366-2373
18. Sandler A, Gray R, Perry M, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. NEJM 355:2542-2550
19. Sasaki Y, Saijo N, Tamura T (1987) Comparison of the antitumor activity of cisplatin and its derivatives with special stress on the pharmacokinetics of active form of drugs in the plasma determined by colony assay. Proc Am Soc Clin Oncol 6:34
20. Shirai T, Hirose T, Noda M, Ando K, Ishida H, Hosaka T, Ozawa T, Okuda K, Ohnishi T, Ohmori T, Horichi N, Adachi M (2006) Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small cell lung cancer. Lung Cancer 52:181-187
21. Schuette W, Blankenburg T, Guschall W, Dittrich I, Schroeder M, Schweisfurth H, Chemaissani A, Schumann C, Dickgreber N, Appel T, Ukena D (2006) Muliticenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every 3-week versus weekly paclitaxel/ carboplatin. Clin Lung Cancer 7:338-343
22. Seidman AD, Hudis CA, Albanel J, Tong W, Tepler I, Currie V, Moynahan ME, Theodoulou M, Gollub M, Baselga J, Norton L (1998) Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. J Clin Oncol 16:3353-3361
23. Sekine I, Nokihara H, Horiike A, Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Saijo N (2004) Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma. Br J Cancer 90:1152-1158
24. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH (2002) Eastern Cooperative Oncology Group Comparison of four chemotherapy regimens for advanced non-small-cell cancer. N Engl J Med 346:92-98
25. Shiratori O, Kanai H, Uchida N (1985) (eds) Recent advances in chemotherapy: antitumor activity of 254-S, a platinum complex, in rodents. University of Tokyo Press, Tokyo
26. Socinski MA, Ivanova A, Bakri K, Wall J, Baggstrom MQ, Hensing TA, Mears A, Tynan M, Beaumont J, Peterman H, Niell HB (2006) A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small-cell lung cancer. Ann Oncol 17:104-109
27. Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP (2006) Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer. J Clin Oncol 24:5330-5331
28. Yamada H, Uchida N, Maekawa R, Yoshioka T (2001) Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel. Cancer Lett 172:17-25
29. Yoshiike F, Koizumi T, Kitaguchi Y Hatayama O, Yasuo M, Sasabayashi M, Wakamatsu H, Fujimoto K, Kubo K (2005) Phase I trial of nedaplatin and paclitaxel for patients with non-small cell lung cancer. J Chemother 17:550-554